Search results
Showing 1081 to 1095 of 1214 results for pain
Baricitinib for treating moderate to severe atopic dermatitis (TA681)
Evidence-based recommendations on baricitinib for treating moderate to severe atopic dermatitis in adults.
Lanadelumab for preventing recurrent attacks of hereditary angioedema (TA606)
Evidence-based recommendations on lanadelumab (Takhzyro) for preventing recurrent attacks of hereditary angioedema in people aged 12 and over.
NICE has developed a Medtech Innovation Briefing (MIB) on Aixplorer ShearWave Elastography for ultrasound imaging and assessing suspicious breast lesions
EarlySense for heart and respiratory monitoring and predicting patient deterioration (MIB49)
NICE has developed a medtech innovation briefing (MIB) on EarlySense for heart and respiratory monitoring and predicting patient deterioration
Percutaneous intradiscal electrothermal therapy for lower back pain (IPG81)
This guidance has been updated and replaced by NICE interventional procedure guidance 319.
Percutaneous intradiscal radiofrequency thermocoagulation for lower back pain (IPG83)
Interventional procedures, IPG83 - Issued: August 2004 --> This guidance has been updated and replaced by NICE interventional procedure guidance 545.
Percutaneous intradiscal electrothermal therapy for low back pain (IPG319)
Interventional procedures, IPG319 - Issued: November 2009 --> This guidance has been updated and replaced by NICE interventional procedure guidance 544.
Digital therapy for chronic tic disorders and Tourette syndrome: early value assessment (HTG748)
Early value assessment (EVA) guidance on digital therapy for chronic tic disorders and Tourette syndrome.
Evidence-based recommendations on automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers.
Evidence-based recommendations on Memokath 051 Ureter stent for ureteric obstruction.
Percutaneous disc decompression using coblation for lower back pain (IPG173)
This guidance has been updated and replaced by NICE interventional procedure guidance 543.
Peripheral nerve-field stimulation for chronic low back pain (IPG451)
Interventional procedures, IPG451 - Issued: March 2013 --> We have moved interventional procedures guidance 451 to become HealthTech guidance 309. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
What is the clinical and cost effectiveness of opioids for the management of acute sciatica?
Source guidance details Comes from guidance Low back pain and sciatica in over 16s: assessment and management Number NG59
Zanubrutinib for treating Waldenstrom's macroglobulinaemia (TA833)
Evidence-based recommendations on zanubrutinib (Brukinsa) for treating Waldenstrom’s macroglobulinaemia in adults.
Evidence-based recommendations on apalutamide with androgen deprivation therapy for treating high-risk hormone-relapsed non-metastatic prostate cancer in adults.